CCT239065 is a novel, selective, and efficacious nanomolar pyridopyrazinone V600EBRAF and LCK inhibitor with IC50 of 13 and 6 nM, respectively. CCT239065 is active against oncogenic BRAF in cells. CCT239065 also inhibits BRAF, CRAF and SRC with IC50 of 81, 12 and 23 nM, respectively. CCT239065 is more than 6-fold less active against wild-type BRAF and more than 50-fold less active against EGFR2/KDR than against V600EBRAF. CCT239065 inhibits ERK1/2 phosphorylation at 5 nM in WM266.4 cells. CCT239065 achieves high levels of selectivity in vitro and at 1 μM, a concentration that is approximately 50 times higher than its IC50 value against purified V600EBRAF. CCT239065 reveals a very low plasma clearance (0.4 mL/hour) consistent with the absence of metabolism and a terminal half-life of 6.8 hours.Plasma concentrations of CCT239065 achieve over 100-fold greater than the average GI50 value for BRAF mutant cancer cell lines in vitro and are sustained above the average GI50 in plasma and muscle (used as a tumor tissue surrogate) for over 18 hours. CCT239065 is well tolerated in mice and displays excellent oral bioavailability. Inhibition of V600EBRAF-mediated signaling in human tumor xenografts is observed following oral administration of a single dose of CCT239065.
|Body Surface Area (m2)||0.007||0.025||0.15||0.05||0.02||0.5|
|Animal A (mg/kg) = Animal B (mg/kg) multiplied by||Animal B Km|
|Animal A Km|
For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.
|Related DNA/RNA Synthesis Products|
Vidarabine is an antiviral drug by interfering with the synthesis of viral DNA, used to treat herpes simplex and varicella zoster viruses.
Uridine is a nucleoside, contains a uracil attached to a ribose ring via a β-N1-glycosidic bond.
Rifampin is a DNA-dependent RNA polymerase inhibitor, used to treat a number of bacterial infections.
Mitomycin C is an antineoplastic antibiotic by inhibiting DNA synthesis, used to treat different cancers.
Mercaptopurine is a widely used antileukemic agent and immunosuppressive drug that inhibits de novo purine synthesis through incorporation of thiopurine methyltransferase metabolites into DNA and RNA.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2017 AbMole BioScience. All Rights Reserved.